More data. Cleaner data. Faster insights.
Utilize traditional measures along with digital biomarkers, ecological momentary
assessments, actigraphy, and passive health data to better understand the patient journey and be
responsive to FDA requirements and questions.
Utilize validated analytics tools across
data modalities for precision insights around treatment effect to inform the design of follow-on
trials.
Activate, execute, and close your studies in a fraction of the time to generate
savings and increase pipeline velocity and value.
Leverage data insights to enhance
subject selection, rater and site quality, and mitigate execution risk.
Shorter, smaller trials
Collection of more data and selection of the right subjects can support more agile and effective trial designs and decisions.
- Exponentially more data collected more quickly to satisfy regulatory demands in shorter, smaller trials
- Treatment-effect prediction
- Faster fail-or-file decisions
Lower site and subject burden
Data collected agnostic to source.
- Fewer devices required to collect data through streamlined integration
- Single sign-on capability for users across devices
- Complete web-based solution
Precision, evidence-based insights
Structured multimodal data makes assessment data, recordings, scores, and quality signals easier to review and defend.
- FDA-required data captured in one platform
- Clinical review and surveillance support
- Platform-generated audit reports
Buyer impact
Built to meet sponsor needs and exceed sponsor expectations
EMA Wellness connects the clinical, operational, data, and financial story into one decision-ready platform narrative.
Reduce regulatory risk before submission
Cleaner data supports faster decisions, stronger evidence packages, and higher quality submissions. Sponsor value increases when FDA, patient, and site needs are addressed together.
Control fragmented trial execution
Avoid disconnected technology and data systems, achieve clearer visibility and less friction across sites, raters, and data workflows.
Endpoint reliability
Support endpoint interpretation through quality oversight, adjudication, and clinical reviews across assessments and recordings.
Leverage analysis-ready clinical datasets
Standardized cross-modal datasets designed for analytics, APIs, LLM quality review, and sponsor data lakes.
Cut costs and avoid noise
Reduce cleanup, reconciliation, and manual oversight while supporting faster trial execution.
Simplify assessments
Flexible workflows make participation, assessments, reviews, and follow-up easier with minimal site, rater, and patient burden.
Stakeholder alignment
Leverage technology and data to speed regulatory approvals
EMA Wellness frames trial infrastructure around the stakeholders that determine whether data is usable, participation is practical, and evidence is reviewable.
Regulatory satisfaction
Standardized, timestamped, review-ready data supports real-time visibility relative to evidence required by regulators for each trial or compound.
Patients
Reduce patient burden by enabling flexible data collection that meets patients where they are and fits more naturally into daily life.
Sites
Simpler data collection and 24/7 site support.
Sponsors
More flexible trial designs to meet needs, evidence-based insights, risk mitigation with time and cost savings.
Commercial outcome
Fail faster or file stronger
Earlier signal visibility, fewer preventable data issues, and stronger evidence help teams make better decisions before cost and risk compound.
Speed
Earlier visibility and faster decision cycles.
Cost control
Less cleanup, reconciliation, and manual review burden.
Quality
Cleaner, more reviewable outcomes evidence across modalities.
Confidence
Better support for trial design, execution, and results.
Make the business case for cleaner trial intelligence.
Align clinical, data, operations, and finance stakeholders around faster access to cleaner, more actionable data.
Meet the team →